Berg, David D. http://orcid.org/0000-0002-0366-5492
Yeh, Robert W.
Mauri, Laura
Morrow, David A.
Kereiakes, Dean J.
Cutlip, Donald E.
Gao, Qi
Jarolim, Petr
Michelson, Alan D.
Frelinger, Andrew L. III
Cange, Abby L.
Sabatine, Marc S.
O’Donoghue, Michelle L.
Funding for this research was provided by:
National Institutes of Health (R01HL098082)
Article History
First Online: 18 July 2020
Compliance with ethical standards
:
: Dr. Berg has nothing to disclose. Dr. Yeh has received Consulting Fees and Research Grants from Abbott Vascular, AstraZeneca, Boston Scientific and Medtronic. Laura Mauri is currently a Full-Time Employee of Medtronic. Dr. Morrow has received Grants and Personal Fees from Abbott Laboratories, AstraZeneca, Roche Diagnostics, and Bayer Pharma; Grants from Novartis, BRAHMS, Daiichi-Sankyo, Eisai, GlaxoSmithKline, Takeda, Pfizer, Quark, The Medicines Company, Merck, and Zora Diagnostics; Personal Fees from InCarda, Aralez, Peloton, and Verseon. He is a Member of the TIMI Study Group, for which he has received Institutional Research Grant support through Brigham and Women’s Hospital from Abbott, Amgen, Aralez, AstraZeneca, Bayer HealthCare Pharmaceuticals, Inc., BRAHMS, Daiichi Sankyo, Eisai, GlaxoSmithKline, Intarcia, Janssen, MedImmune, Merck, Novartis, Pfizer, Poxel, Quark Pharmaceuticals, Roche, Takeda, The Medicines Company, and Zora Biosciences. Dr. Cutlip has received Consulting Fees from Celonova. Ms. Gao has nothing to disclose. Dr. Jarolim has received Research Grants through his institution from Abbott Laboratories, Amgen, Inc., AstraZeneca, LP, Daiichi-Sankyo, Inc., GlaxoSmithKline, Merck and Co, Inc., Roche Diagnostics Corporation, Takeda Global Research and Development Center, and Waters Technologies Corporation; and Consulting Fees from Roche Diagnostics Corporation. Dr. Michelson has received Research Grants from Ironwood Pharmaceuticals. Dr. Frelinger has received Research Grants from Ironwood Pharmaceuticals. Dr. Cange has nothing to disclose. Dr. Sabatine reports Grants from AstraZeneca during the conduct of the study; Grants and Personal Fees from Amgen, Personal Fees from Anthos Therapeutics, Grants and Personal Fees from AstraZeneca, Grants from Bayer, Personal Fees from Bristol-Myers Squibb, Personal Fees from CVS Caremark, Grants from Daiichi-Sankyo, Personal Fees from DalCor, Personal Fees from Dyrnamix, Grants from Eisai, Personal Fees from Esperion, Grants from GlaxoSmithKline, Personal Fees from IFM Therapeutics, Grants and Personal Fees from Intarcia, Personal Fees from Ionis, Grants and Personal Fees from Janssen Research and Development, Grants and Personal Fees from Medicines Company, Grants and Personal Fees from MedImmune, Grants and Personal Fees from Merck, Grants and Personal Fees from Novartis, Grants from Pfizer, Grants from Poxel, Grants from Quark Pharmaceuticals, Grants from Takeda, outside the submitted work; and is a Member of the TIMI Study Group, which has also received Institutional Research Grant support through Brigham and Women’s Hospital from: Abbott, Aralez, Roche, and Zora Biosciences. Dr. O’Donoghue has received Research Grants from GlaxoSmithKline, Janssen, The Medicines Company, and Merck.
: Ethics approval was obtained for all participating institutions.
: Informed consent was obtained for all participants. Patients were informed of intent to publish study results.